Evidence map›Paper›PMID 24212825›Full record

ArticleCancers2011

Regulation of autophagy by kinases.

Savitha Sridharan, Kirti Jain, Alakananda Basu

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 180 citations in OpenAlex.

  1. Article
  2. Review
  3. Pbs2 regulates late-stage macroautophagy in Saccharomyces cerevisiae.Animal models and experimental medicine · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Pennogenin-3-Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Chemosensitization Effect of Seabuckthorn (Foods (Basel, Switzerland) · 2022
    Article
  10. Ouabain-NaNeurochemical research · 2022
    Article
  11. Article
  12. Role of autophagy in intervertebral disc degeneration.Journal of cellular physiology · 2022
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Molecular and cellular pathways contributing to brain aging.Behavioral and brain functions : BBF · 2021
    Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Savitha SridharanDepartment of Molecular Biology and Immunology, University of North Texas Health Science Center and Institute for Cancer Research, Fort Worth, TX 76107, USA. alakananda.basu@unthsc.edu.
Kirti Jain
Alakananda Basu
University of North Texas Health Science Center · USUniversity of North Texas · US

Funding

TUMOR NECROSIS FACTOR ALPHA SIGNALING IN BREAST CANCERR01CA071727 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BASU, ALAKANANDA · 1997 to 2009
$1.3M
NCI NIH HHS R01 CA071727
6 · The paper itself

Abstract

Autophagy is a process of self-degradation that maintains cellular viability during periods of metabolic stress. Although autophagy is considered a survival mechanism when faced with cellular stress, extensive autophagy can also lead to cell death. Aberrations in autophagy are associated with several diseases, including cancer. Therapeutic exploitation of this process requires a clear understanding of its regulation. Although the core molecular components involved in the execution of autophagy are well studied there is limited information on how cellular signaling pathways, particularly kinases, regulate this complex process. Protein kinases are integral to the autophagy process. Atg1, the first autophagy-related protein identified, is a serine/threonine kinase and it is regulated by another serine/threonine kinase mTOR. Emerging studies suggest the participation of many different kinases in regulating various components/steps of this catabolic process. This review focuses on the regulation of autophagy by several kinases with particular emphasis on serine/threonine protein kinases such as mTOR, AMP-activated kinase, Akt, mitogen-activated protein kinase (ERK, p38 and JNK) and protein kinase C that are often deregulated in cancer and are important therapeutic targets.

Identifiers

PMID24212825
PMCPMC3757434
OpenAlexW2167259878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.